EP0680607A4 - Methode de dosage permettant d'identifier la rupture des membranes chez les femmes presentant un risque d'accouchement imminent. - Google Patents

Methode de dosage permettant d'identifier la rupture des membranes chez les femmes presentant un risque d'accouchement imminent.

Info

Publication number
EP0680607A4
EP0680607A4 EP94906621A EP94906621A EP0680607A4 EP 0680607 A4 EP0680607 A4 EP 0680607A4 EP 94906621 A EP94906621 A EP 94906621A EP 94906621 A EP94906621 A EP 94906621A EP 0680607 A4 EP0680607 A4 EP 0680607A4
Authority
EP
European Patent Office
Prior art keywords
sample
igfbp
delivery
patient
membranes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94906621A
Other languages
German (de)
English (en)
Other versions
EP0680607A1 (fr
Inventor
John C Leavitt
David C Casal
Madhu Varma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adeza Biomedical Corp
Original Assignee
Adeza Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adeza Biomedical Corp filed Critical Adeza Biomedical Corp
Publication of EP0680607A1 publication Critical patent/EP0680607A1/fr
Publication of EP0680607A4 publication Critical patent/EP0680607A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Definitions

  • the IGFBP-1 test can be repeated, preferably daily, until the sample is positive for IGFBP-1.
  • a marker such as fibronectin which can be positive as much as weeks earlier than fetal fibronectin has been used, the marker which appears closest to delivery can be tested. If the delivery marker is positive and IGFBP-1 is not present in the sample, measures to determine or enhance fetal lung maturity can be undertaken. For example, an amniotic fluid sample can be analyzed for phospholipids. In general, patients at risk for preterm delivery are examined every two weeks from about 22 to 36 weeks, rather than every four weeks as for patients in a low risk category. All patients are examined weekly from about week 36.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP94906621A 1993-01-22 1994-01-21 Methode de dosage permettant d'identifier la rupture des membranes chez les femmes presentant un risque d'accouchement imminent. Withdrawn EP0680607A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US743293A 1993-01-22 1993-01-22
US7432 1993-01-22
PCT/US1994/000455 WO1994017405A1 (fr) 1993-01-22 1994-01-21 Methode de dosage permettant d'identifier la rupture des membranes chez les femmes presentant un risque d'accouchement imminent

Publications (2)

Publication Number Publication Date
EP0680607A1 EP0680607A1 (fr) 1995-11-08
EP0680607A4 true EP0680607A4 (fr) 1997-06-04

Family

ID=21726119

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94906621A Withdrawn EP0680607A4 (fr) 1993-01-22 1994-01-21 Methode de dosage permettant d'identifier la rupture des membranes chez les femmes presentant un risque d'accouchement imminent.

Country Status (4)

Country Link
EP (1) EP0680607A4 (fr)
JP (3) JP3742649B2 (fr)
CA (1) CA2152676A1 (fr)
WO (1) WO1994017405A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ283658A (en) * 1994-04-04 1999-09-29 William R Freeman Compositions and treatment of increased intraocular pressure with phosphonyl-alkyloxy-pyrimidines/purines (nucleosides)
US5597700A (en) * 1994-04-28 1997-01-28 California Research, Llc Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method
US6678669B2 (en) 1996-02-09 2004-01-13 Adeza Biomedical Corporation Method for selecting medical and biochemical diagnostic tests using neural network-related applications
EP0987269B1 (fr) 1997-05-30 2003-08-13 Sankyo Company Limited Sels de derive de sulfoxyde optiquement actif
EP1936376B1 (fr) 2003-02-06 2012-04-11 Hologic Inc. Procédés de criblage et de traitement pour la prévention des accouchements prématurés
DK2299275T3 (en) 2004-07-30 2018-05-07 Adeza Biomedical Corp Classification of oncofetal fetronectin level for pregnancy-related indications
US7863007B2 (en) * 2005-09-15 2011-01-04 Swiss Asian Property Limited Marker for prolonged rupture of membranes
JP4952164B2 (ja) * 2006-09-20 2012-06-13 株式会社デンソー 流量計測素子、質量流量計
CN103543273A (zh) * 2013-11-04 2014-01-29 无锡博慧斯生物医药科技有限公司 一种孕妇早产胎儿纤维连接蛋白和磷酸化胰岛素样生长因子结合蛋白-1联检试剂盒
WO2017170824A1 (fr) * 2016-03-31 2017-10-05 積水メディカル株式会社 Procédé de détection de fibronectine oncofœtale par dosage immunologique simple
WO2023032925A1 (fr) * 2021-08-30 2023-03-09 国立大学法人京都大学 Méthode et réactif de test

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337394C (fr) * 1987-11-17 1995-10-24 Nelson N. H. Teng Test a prelevement vaginal et reactifs
US5096830A (en) * 1987-11-17 1992-03-17 Adeza Biomedical Corporation Preterm labor and membrane rupture test
FI86777C (fi) * 1990-12-31 1992-10-12 Medix Biochemica Ab Oy Foerfarande foer diagnosticering av bristningen av fosterhinnorna samt reagensfoerpackning foer anvaendning daervid

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
H.S. WANG ET AL.: "Levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in pregnancy with preterm delivery", BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, vol. 100, no. 5, 1 May 1993 (1993-05-01), OXFORD UK, pages 472 - 475, XP000646845 *
M. FANT: "Insulin-like growth factor binding proteins (BP) from human placenta are immunologically related to the growth hormone dependent binding protein in adult human serum (BP-53).", PLACENTA, vol. 11, no. 2, 1990, DALLAS TY USA, pages 123 - 133, XP000646849 *
S.L.S. DROP ET AL.: "Isolation of a somatomedin-binding protein from preterm amniotic fluid.", JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, vol. 59, no. 5, 1984, WASHINGTON DC USA, pages 899 - 907, XP000646852 *
See also references of WO9417405A1 *

Also Published As

Publication number Publication date
CA2152676A1 (fr) 1994-08-04
JP3943575B2 (ja) 2007-07-11
JP2004125807A (ja) 2004-04-22
WO1994017405A1 (fr) 1994-08-04
EP0680607A1 (fr) 1995-11-08
JPH08506658A (ja) 1996-07-16
JP3742649B2 (ja) 2006-02-08
JP2005326427A (ja) 2005-11-24

Similar Documents

Publication Publication Date Title
JP3943575B2 (ja) 切迫分娩についての危険にある女性における膜の破裂を決定するための検定方法
US5516702A (en) Screening method for identifying women at increased risk for imminent delivery
EP0642667B1 (fr) Procede de depistage pour l'identification de femmes presentant un risque accru d'accouchement avant terme
EP1936376B1 (fr) Procédés de criblage et de traitement pour la prévention des accouchements prématurés
US5281522A (en) Reagents and kits for determination of fetal fibronectin in a vaginal sample
US5096830A (en) Preterm labor and membrane rupture test
US7892774B2 (en) Diagnostic method for determining the susceptibility to delivery and reagent kit for use therefor
Klentzrics et al. Placental protein 14 in cycles with normal and retarded endometrial differentiation
US5468619A (en) Screening method for identifying women at increased risk for imminent delivery
EP0316919A2 (fr) Echantillon vaginal, essai et réactifs
EP1914553A1 (fr) Procédé d'identification de femmes ayant un risque accru de retard de croissance fýtal
US5236846A (en) Ectopic pregnancy test
WO1993024836A1 (fr) Methode de depistage de femmes presentant un risque eleve d'accouchement avant terme
EP1756584A2 (fr) Fraction pag-55 enrichie et methodes de detection precoce d'une gestation chez des animaux ongules
WO1993024838A1 (fr) Methode de depistage permettant de depister chez les femmes le risque d'accouchement avant terme
WO1999058974A1 (fr) Procede et dispositif de test d'evaluation de la maturite cervicale a terme avec des isoformes de igfpb-1 fortement phosphorylees
AU620351B2 (en) Vaginal sample test and reagents

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950811

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE ES FR GB IT

RHK1 Main classification (correction)

Ipc: G01N 33/53

A4 Supplementary search report drawn up and despatched

Effective date: 19970416

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): DE ES FR GB IT

17Q First examination report despatched

Effective date: 19991028

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000308

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1014576

Country of ref document: HK